Product Code: ETC4469545 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The preclinical imaging market in India supports research and drug development by providing non-invasive imaging solutions for small animal models. As the pharmaceutical and biotechnology sectors expand, the demand for preclinical imaging systems for drug testing and disease research is on the rise. This market is expected to grow in tandem with the life sciences industry.
The India Preclinical Imaging Market is expanding as pharmaceutical and biotechnology companies invest in research and development. Preclinical imaging plays a pivotal role in the drug discovery and development process, allowing for non-invasive and real-time assessment of drug efficacy. As the India pharmaceutical industry continues to grow, the demand for preclinical imaging technologies is expected to increase in parallel.
The preclinical imaging market in India faces challenges linked to the relatively small number of research institutions and pharmaceutical companies investing in this technology. The cost of advanced preclinical imaging equipment and the need for specialized training can be barriers to entry. Regulatory compliance and ethical considerations regarding the use of animals in preclinical studies add complexity. The market also needs to establish more comprehensive standards and guidelines to ensure the quality and accuracy of preclinical imaging data.
The COVID-19 pandemic had a mixed impact on the India preclinical imaging market. While the disruptions in research activities and laboratory access led to challenges in conducting preclinical imaging studies, the importance of preclinical imaging in drug development, especially for COVID-19-related research, remained significant. The pandemic accelerated the adoption of advanced preclinical imaging modalities for studying disease models and developing therapies. As research activities resume and the focus on drug development continues, the preclinical imaging market is expected to recover and grow.
In this sector, key players in India include PerkinElmer, Bruker, MILabs, and Aspect Imaging.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Preclinical Imaging Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Preclinical Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 India Preclinical Imaging Market - Industry Life Cycle |
3.4 India Preclinical Imaging Market - Porter's Five Forces |
3.5 India Preclinical Imaging Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 India Preclinical Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Preclinical Imaging Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 India Preclinical Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in the pharmaceutical and biotechnology sectors in India. |
4.2.2 Growing demand for non-invasive imaging techniques for preclinical research. |
4.2.3 Government initiatives to promote healthcare infrastructure and innovation in the country. |
4.3 Market Restraints |
4.3.1 High cost associated with preclinical imaging equipment and services. |
4.3.2 Lack of skilled professionals in the field of preclinical imaging in India. |
4.3.3 Stringent regulatory requirements for preclinical imaging research. |
5 India Preclinical Imaging Market Trends |
6 India Preclinical Imaging Market, By Types |
6.1 India Preclinical Imaging Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India Preclinical Imaging Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 India Preclinical Imaging Market Revenues & Volume, By CT Imaging, 2021-2031F |
6.1.4 India Preclinical Imaging Market Revenues & Volume, By MRI Imaging, 2021-2031F |
6.1.5 India Preclinical Imaging Market Revenues & Volume, By PET/SPECT Imaging, 2021-2031F |
6.1.6 India Preclinical Imaging Market Revenues & Volume, By Multi-modal Imaging, 2021-2031F |
6.1.7 India Preclinical Imaging Market Revenues & Volume, By Optical Imaging, 2021-2031F |
6.1.8 India Preclinical Imaging Market Revenues & Volume, By Ultrasound Imaging, 2021-2031F |
6.1.9 India Preclinical Imaging Market Revenues & Volume, By Reagents, 2021-2031F |
6.1.10 India Preclinical Imaging Market Revenues & Volume, By Reagents, 2021-2031F |
6.2 India Preclinical Imaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Preclinical Imaging Market Revenues & Volume, By Research and Development, 2021-2031F |
6.2.3 India Preclinical Imaging Market Revenues & Volume, By Drug Discovery, 2021-2031F |
6.3 India Preclinical Imaging Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 India Preclinical Imaging Market Revenues & Volume, By Biotech Companies, 2021-2031F |
6.3.3 India Preclinical Imaging Market Revenues & Volume, By Pharmaceutical companies, 2021-2031F |
6.3.4 India Preclinical Imaging Market Revenues & Volume, By Research institutes, 2021-2031F |
7 India Preclinical Imaging Market Import-Export Trade Statistics |
7.1 India Preclinical Imaging Market Export to Major Countries |
7.2 India Preclinical Imaging Market Imports from Major Countries |
8 India Preclinical Imaging Market Key Performance Indicators |
8.1 Number of new research collaborations between academic institutions and pharmaceutical companies in the field of preclinical imaging. |
8.2 Percentage increase in adoption of preclinical imaging techniques in academic and research institutions. |
8.3 Number of government grants and funding allocated to support preclinical imaging research and infrastructure development in India. |
9 India Preclinical Imaging Market - Opportunity Assessment |
9.1 India Preclinical Imaging Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 India Preclinical Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Preclinical Imaging Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 India Preclinical Imaging Market - Competitive Landscape |
10.1 India Preclinical Imaging Market Revenue Share, By Companies, 2024 |
10.2 India Preclinical Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |